Not Signed In -
Goserelin |
Zoladex |
Image:Goserelin.png Goserelin Systematic (IUPAC) name N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2- [(carbamoylamino)carbamoyl]pyrrolidin-1-yl]- 5-(diaminomethylideneamino)-1-oxo -pentan-2-yl]carbamoyl]-3-methyl- butyl]carbamoyl]-2-tert-butoxy- ethyl]carbamoyl]-2-(4-hydroxyphenyl) ethyl]carbamoyl]-2-hydroxy-ethyl] carbamoyl]-2-(1H-indol-3-yl)ethyl] carbamoyl]-2-(3H-imidazol-4-yl)ethyl]- 5-oxo-pyrrolidine-2-carboxamide Identifiers CAS number 65807-02-5 ATC code L02AE03 PubChem 47725 Dr ...
Wikipedia - [full article]
Goserelin Clinical Trials
- Leuprolide or Goserelin Plus Thalidomide Compared With Leuprolide or Goserelin Alone in Treating Patients With Nonmetastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00020085 - Active, not recruiting
Prostate Cancer
- Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00010010 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
ClinicalTrials.gov Identifier: NCT00012090 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)
ClinicalTrials.gov Identifier: NCT00196846 - Active, not recruiting
Breast Cancer
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00014586 - Active, not recruiting
stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00021450 - Recruiting
stage II prostate cancer
- Goserelin in Preventing Ovarian Failure in Women Receiving Adjuvant Chemotherapy for Breast Cancer
ClinicalTrials.gov Identifier: NCT00068601 - Recruiting
Breast Cancer; Hot Flashes; menopausal symptoms; Osteoporosis; sexual dysfunction and infertility
- Study of External Beam Radiation Therapy with and Without Hormonal Therapy to Treat Prostate Cancer
ClinicalTrials.gov Identifier: NCT00116220 - Active, not recruiting
Prostate Cancer
- Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00423475 - Recruiting
Prostate Cancer
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00430183 - Recruiting
Prostate Cancer
- Dose-Response of Gonadal Steroids and Bone Turnover in Men
ClinicalTrials.gov Identifier: NCT00114114 - Recruiting
Healthy volunteers
- Immediate vs Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy.
ClinicalTrials.gov Identifier: NCT00439751 - Recruiting
Prostate Cancer
- Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00498901 - Recruiting
Breast Cancer
- Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00429403 - Recruiting
Breast Cancer
- Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00427245 - Recruiting
Breast Cancer; Menopausal Symptoms; Sexual Dysfunction and Infertility
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Operable Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00002580 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
ClinicalTrials.gov Identifier: NCT00031850 - Completed
Breast Cancer
- Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
ClinicalTrials.gov Identifier: NCT00002460 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002597 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002889 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Goserelin Plus Letrozole in Premenopausal Patients Versus Letrozole Alone in Postmenopausal Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00532272 - Recruiting
Breast Cancer; Metastatic
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00002582 - Active, not recruiting
stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
- Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer; bone metastases
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00217659 - Completed
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Combination Chemotherapy in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00047099 - Recruiting
stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
- Hormone Therapy in Treating Men With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002651 - Recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00104715 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00055731 - Recruiting
stage III prostate cancer; stage II prostate cancer
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-Positive Patients
ClinicalTrials.gov Identifier: NCT00309478 - Completed
Early-Stage Breast Cancer
- Pazopanib After Leuprolide or Goserelin in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00454571 - Suspended
Prostate Cancer
- Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00032006 - Completed
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
- Flutamide, Suramin, and Hydrocortisone in Treating Patients with Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002881 - Completed
stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
email this page
print this page
bookmark this page
feedback on this page
